ID   PHOP1_HUMAN             Reviewed;         267 AA.
AC   Q8TCT1; E9PAM0; Q17RU6;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-MAR-2017, entry version 112.
DE   RecName: Full=Phosphoethanolamine/phosphocholine phosphatase;
DE            EC=3.1.3.75;
GN   Name=PHOSPHO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12464021; DOI=10.1046/j.1365-2052.2002.00900.x;
RA   Houston B., Paton I.R., Burt D.W., Farquharson C.;
RT   "Chromosomal localization of the chicken and mammalian orthologues of
RT   the orphan phosphatase PHOSPHO1 gene.";
RL   Anim. Genet. 33:451-454(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RX   PubMed=18471996; DOI=10.1016/j.bbrc.2008.04.163;
RA   Roberts S.J., Owen H.C., Farquharson C.;
RT   "Identification of a novel splice variant of the haloacid
RT   dehalogenase: PHOSPHO1.";
RL   Biochem. Biophys. Res. Commun. 371:872-876(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-111 (ISOFORM 3).
RC   TISSUE=Colon, and Medulla oblongata;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15175005; DOI=10.1042/BJ20040511;
RA   Roberts S.J., Stewart A.J., Sadler P.J., Farquharson C.;
RT   "Human PHOSPHO1 exhibits high specific phosphoethanolamine and
RT   phosphocholine phosphatase activities.";
RL   Biochem. J. 382:59-65(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15050893; DOI=10.1016/j.bone.2003.12.023;
RA   Houston B., Stewart A.J., Farquharson C.;
RT   "PHOSPHO1 -- a novel phosphatase specifically expressed at sites of
RT   mineralisation in bone and cartilage.";
RL   Bone 34:629-637(2004).
RN   [7]
RP   SIMILARITY TO HAD-LIKE HYDROLASE SUPERFAMILY.
RX   PubMed=14983068; DOI=10.1093/protein/gzg126;
RA   Stewart A.J., Schmid R., Blindauer C.A., Paisey S.J., Farquharson C.;
RT   "Comparative modelling of human PHOSPHO1 reveals a new group of
RT   phosphatases within the haloacid dehalogenase superfamily.";
RL   Protein Eng. 16:889-895(2003).
RN   [8]
RP   MUTAGENESIS OF ASP-32; ASP-43; ASP-123 AND ASP-203.
RX   PubMed=16054448; DOI=10.1016/j.bbapap.2005.06.009;
RA   Roberts S.J., Stewart A.J., Schmid R., Blindauer C.A., Bond S.R.,
RA   Sadler P.J., Farquharson C.;
RT   "Probing the substrate specificities of human PHOSPHO1 and PHOSPHO2.";
RL   Biochim. Biophys. Acta 1752:73-82(2005).
CC   -!- FUNCTION: Phosphatase that has a high activity toward
CC       phosphoethanolamine (PEA) and phosphocholine (PCho). Involved in
CC       the generation of inorganic phosphate for bone mineralization.
CC   -!- CATALYTIC ACTIVITY: O-phosphoethanolamine + H(2)O = ethanolamine +
CC       phosphate. {ECO:0000269|PubMed:15175005}.
CC   -!- CATALYTIC ACTIVITY: Phosphocholine + H(2)O = choline + phosphate.
CC       {ECO:0000269|PubMed:15175005}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15175005};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3 uM for PEA {ECO:0000269|PubMed:15175005};
CC         KM=11.4 uM for PCho {ECO:0000269|PubMed:15175005};
CC       pH dependence:
CC         Optimum pH is 6.7. {ECO:0000269|PubMed:15175005};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TCT1-1; Sequence=Displayed;
CC       Name=2; Synonyms=PHOSPHO1-3a;
CC         IsoId=Q8TCT1-2; Sequence=VSP_040624;
CC       Name=3;
CC         IsoId=Q8TCT1-3; Sequence=VSP_045709;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at sites of mineralization in bone
CC       and cartilage. Highly expressed in osteoblast cell line SaOS-2
CC       which produces a mineralized matrix, but not in MG-63 cell line,
CC       which do not mineralize. {ECO:0000269|PubMed:15050893}.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. PHOSPHO
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ457189; CAD29803.1; -; mRNA.
DR   EMBL; AC004797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029931; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC117187; AAI17188.1; -; mRNA.
DR   CCDS; CCDS11547.1; -. [Q8TCT1-1]
DR   CCDS; CCDS45726.1; -. [Q8TCT1-3]
DR   RefSeq; NP_001137276.1; NM_001143804.1. [Q8TCT1-3]
DR   RefSeq; NP_848595.1; NM_178500.3. [Q8TCT1-1]
DR   UniGene; Hs.405607; -.
DR   ProteinModelPortal; Q8TCT1; -.
DR   BioGrid; 127819; 4.
DR   STRING; 9606.ENSP00000406909; -.
DR   BindingDB; Q8TCT1; -.
DR   ChEMBL; CHEMBL6113; -.
DR   DrugBank; DB00122; Choline.
DR   DEPOD; Q8TCT1; -.
DR   iPTMnet; Q8TCT1; -.
DR   PhosphoSitePlus; Q8TCT1; -.
DR   BioMuta; PHOSPHO1; -.
DR   DMDM; 74715842; -.
DR   PaxDb; Q8TCT1; -.
DR   PeptideAtlas; Q8TCT1; -.
DR   PRIDE; Q8TCT1; -.
DR   Ensembl; ENST00000310544; ENSP00000311925; ENSG00000173868. [Q8TCT1-1]
DR   Ensembl; ENST00000413580; ENSP00000406909; ENSG00000173868. [Q8TCT1-3]
DR   Ensembl; ENST00000514112; ENSP00000427694; ENSG00000173868. [Q8TCT1-3]
DR   GeneID; 162466; -.
DR   KEGG; hsa:162466; -.
DR   UCSC; uc002ios.2; human. [Q8TCT1-1]
DR   CTD; 162466; -.
DR   GeneCards; PHOSPHO1; -.
DR   HGNC; HGNC:16815; PHOSPHO1.
DR   HPA; HPA053016; -.
DR   neXtProt; NX_Q8TCT1; -.
DR   OpenTargets; ENSG00000173868; -.
DR   PharmGKB; PA33276; -.
DR   eggNOG; KOG3120; Eukaryota.
DR   eggNOG; ENOG4111NAQ; LUCA.
DR   GeneTree; ENSGT00390000007741; -.
DR   HOGENOM; HOG000231038; -.
DR   HOVERGEN; HBG080058; -.
DR   InParanoid; Q8TCT1; -.
DR   KO; K06124; -.
DR   OMA; SPGMGDL; -.
DR   OrthoDB; EOG091G0GZ1; -.
DR   PhylomeDB; Q8TCT1; -.
DR   TreeFam; TF300112; -.
DR   BioCyc; MetaCyc:HS16266-MONOMER; -.
DR   BRENDA; 3.1.3.75; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   GenomeRNAi; 162466; -.
DR   PRO; PR:Q8TCT1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173868; -.
DR   CleanEx; HS_PHOSPHO1; -.
DR   ExpressionAtlas; Q8TCT1; baseline and differential.
DR   Genevisible; Q8TCT1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0065010; C:extracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; IBA:GO_Central.
DR   GO; GO:0052731; F:phosphocholine phosphatase activity; EXP:Reactome.
DR   GO; GO:0052732; F:phosphoethanolamine phosphatase activity; EXP:Reactome.
DR   GO; GO:0016462; F:pyrophosphatase activity; IDA:MGI.
DR   GO; GO:0035630; P:bone mineralization involved in bone maturation; IBA:GO_Central.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome.
DR   GO; GO:0030500; P:regulation of bone mineralization; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR016965; Pase_PHOSPHO-typ.
DR   InterPro; IPR006384; PyrdxlP_Pase-rel.
DR   PANTHER; PTHR20889; PTHR20889; 1.
DR   Pfam; PF06888; Put_Phosphatase; 1.
DR   PIRSF; PIRSF031051; PyrdxlP_Pase_PHOSPHO2; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01489; DKMTPPase-SF; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Magnesium;
KW   Metal-binding; Mineral balance; Reference proteome.
FT   CHAIN         1    267       Phosphoethanolamine/phosphocholine
FT                                phosphatase.
FT                                /FTId=PRO_0000068829.
FT   ACT_SITE     32     32       Nucleophile. {ECO:0000305}.
FT   ACT_SITE     34     34       Proton donor. {ECO:0000250}.
FT   METAL        32     32       Magnesium. {ECO:0000305}.
FT   METAL        34     34       Magnesium. {ECO:0000250}.
FT   METAL       203    203       Magnesium. {ECO:0000305}.
FT   BINDING      43     43       Substrate. {ECO:0000305}.
FT   BINDING     123    123       Substrate. {ECO:0000305}.
FT   VAR_SEQ       1     15       MSGCFPVSGLRCLSR -> MCQRLWPANQPLPGGLLPRPLS
FT                                LAPSSSSSCCSPPCSQ (in isoform 2).
FT                                {ECO:0000303|PubMed:18471996}.
FT                                /FTId=VSP_040624.
FT   VAR_SEQ       1     15       MSGCFPVSGLRCLSR -> MCQRLWPWPANQPLPGGLLPRP
FT                                LSLAPSSSSSCCSPPCSQ (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045709.
FT   MUTAGEN      32     32       D->N: Abolishes phosphatase activity.
FT                                {ECO:0000269|PubMed:16054448}.
FT   MUTAGEN      43     43       D->N: Strongly reduces reactivity toward
FT                                PEA and PCho substrates. Abolishes
FT                                phosphatase activity; when associated
FT                                with N-123.
FT                                {ECO:0000269|PubMed:16054448}.
FT   MUTAGEN     123    123       D->N: Strongly reduces reactivity toward
FT                                PEA and PCho substrates. Abolishes
FT                                phosphatase activity; when associated
FT                                with N-43. {ECO:0000269|PubMed:16054448}.
FT   MUTAGEN     203    203       D->S: Abolishes phosphatase activity.
FT                                {ECO:0000269|PubMed:16054448}.
SQ   SEQUENCE   267 AA;  29713 MW;  539F65C749D39E81 CRC64;
     MSGCFPVSGL RCLSRDGRMA AQGAPRFLLT FDFDETIVDE NSDDSIVRAA PGQRLPESLR
     ATYREGFYNE YMQRVFKYLG EQGVRPRDLS AIYEAIPLSP GMSDLLQFVA KQGACFEVIL
     ISDANTFGVE SSLRAAGHHS LFRRILSNPS GPDARGLLAL RPFHTHSCAR CPANMCKHKV
     LSDYLRERAH DGVHFERLFY VGDGANDFCP MGLLAGGDVA FPRRGYPMHR LIQEAQKAEP
     SSFRASVVPW ETAADVRLHL QQVLKSC
//
